Partners

Adding differentiated products through Business Development

Partnerships are integral to Hikma’s strategy. We remain focused on building an increasingly diverse specialty portfolio through acquisition and partnership, including licensing of NDA/ANDA, generic medicines and biosimilars to help put better health within reach, every day across our regions.

Also, we offer contract manufacturing capabilities leveraging the quality, reliability and flexibility of our manufacturing facilities. We operate 32 manufacturing plants across the US, Europe and the MENA region.

Please click here to submit your enquiry to Hikma's Business Development team.

Adalvo

Adalvo

Allergic Rhinitis (AR)

AFT Pharmaceuticals

AFT Pharmaceuticals

Intravenous

Almirall

Almirall

Dermatology

Astellas

Astellas

Anti-Infectives and Immunosuppressants

Basilea Pharmaceutica

Basilea Pharmaceutica

Anti-infectives

Bio-Thera Solutions, Ltd.

Bio-Thera Solutions, Ltd.

Monoclonal Antibody

BioSapien Inc

BioSapien Inc

Innovative Therapies

Boehringer Ingelheim

Boehringer Ingelheim

Respiratory Diseases

Celltrion

Celltrion

Biological, Oncology and Rheumatology

Eisai

Eisai

Central Nervous System

FAES Farma

FAES Farma

Allergic Rhinitis and Urticaria

Gedeon Richter Plc.

Gedeon Richter Plc.

Osteoporosis and Fractures

Glenmark

Glenmark

Seasonal allergic rhinitis

Melinta Therapeutics

Melinta Therapeutics

Anti-infective

Octapharma

Octapharma

Blood Forming and Rare Diseases

Orion Pharma

Orion Pharma

Respiratory

Perrigo

Perrigo

Consumer Health

ROVI

ROVI

Blood and Blood Forming and Cardiovascular

Sesen Bio

Sesen Bio

Fusion Protein Therapeutics

Tact.ai

Tact.ai

Customer Engagement

Takeda

Takeda

Cardiovascular, Gastrointestinal and Musco-Skeletal

Vifor Pharma

Vifor Pharma

Blood and Blood-Forming and Anti-Anemic

Last reviewed on 30 May 2022